Bianca Julia J Van Broeck

Title: The Innovations of Bianca Julia J Van Broeck

Introduction

Bianca Julia J Van Broeck is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on addressing critical health issues related to beta-amyloid peptides.

Latest Patents

Bianca holds a patent for "Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof." This invention provides monoclonal antibodies that specifically recognize shorter Aβ peptides obtained after cleavage of the APP protein mediated by γ-secretase. The patent details the Aβ-peptide fragments Aβ1-37, Aβ3-37, Aβ3p-37, Aβ1-37, and Aβ11p-37, along with hybridoma cells producing these antibodies. It also outlines methods for producing the antibodies and hybridoma cells, as well as an immunoassay for measuring the level of Aβx-37 peptides in biological samples.

Career Highlights

Bianca is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work at Janssen has allowed him to contribute to innovative solutions in the healthcare sector. His research has the potential to impact the diagnosis and treatment of diseases related to beta-amyloid peptides.

Collaborations

Bianca has collaborated with notable colleagues, including Marc Mercken and Marianne Borgers. These partnerships have enhanced the research and development of his innovative solutions.

Conclusion

Bianca Julia J Van Broeck is a distinguished inventor whose work in monoclonal antibodies has the potential to advance medical science significantly. His contributions reflect the importance of innovation in addressing complex health challenges.